NCT04724551View on ClinicalTrials.gov

The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula

CompletedOBSERVATIONAL
Enrollment

648

Participants

Timeline

Start Date

June 1, 2012

Primary Completion Date

December 31, 2020

Study Completion Date

February 28, 2021

Conditions
Pancreas Neoplasm
Interventions
PROCEDURE

pancreatoduodenectomy (PD)

A pancreaticogastrostomy or -jejunostomy duct-to-mucosa was achieved according to the surgeon's preference and pancreatic texture.

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT04724551 - The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula | Biotech Hunter | Biotech Hunter